Optruma

raloxifene hydrochloride · Eli Lilly Nederland B.V.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Optruma, covering 2026-01-27 to 2026-01-27. Get the full timeline:

Most recent: EMA Authorised: Optruma (raloxifene hydrochloride) — Eli Lilly Nederland B.V.